Merger and acquisition activities in China increased due to Covid-19
According to GlobalData's Medical Devices Deal Database, key M&A activities in China increased significantly from 2018 to 2021.
2022 So far In Venture Capital
WHO and MPP enter worldwide licencing deal for Covid-19 antibody test
LumiraDx completes merger with CA Health Acquisition
Covid-19 testing firm Prenetics agrees to go public with SPAC merger
LumiraDx and CA Healthcare Acquisition revise merger agreement
Memic agrees to merge with MedTech Acquisition
